GlassScriptPhysician profile
Matthew Ryan Wilson
NPI 1316006083
$16,071.76
in general payments reported to CMS, 2019-2025
27 companies · $1,450 in 2025
The $1,450 reported for 2025 was more than what 78% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $66.39 · 2021: $8,528 · 2022: $1,401 · 2023: $3,811 · 2024: $300 · 2025: $1,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,982 · Travel and Lodging: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,981.92 |
| Travel and Lodging | $578.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,130.54 | 2021-2025 | Davinci Xi, Da Vinci Surgical System |
| Smith+Nephew, INC. | $219.67 | 2019-2025 | Collagenase Santyl, Stravix, Oasis |
| Conmed Corporation | $198.66 | 2022-2023 | Airseal |
| Myriad Genetic Laboratories, INC. | $190.14 | 2022-2023 | Myrisk |
| W. L. Gore & Associates, INC. | $148.35 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $129.84 | 2019-2023 | |
| Medical Device Business Services, INC. | $121.09 | 2024 | Enseal |
| Shire North American Group INC | $104.19 | 2019 | |
| Davol INC. | $103.79 | 2022-2023 | Phasix Mesh |
| Polynovo North America LLC | $102.89 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $94.38 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.01 | 2022-2023 | Gattex |
| Medtronic, INC. | $61.85 | 2023-2025 | Interstim |
| Tei Biosciences INC | $56.88 | 2019 | |
| Medline Industries LP | $41.13 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $38.86 | 2021 | |
| Thd America, INC. | $34.43 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $32.34 | 2023-2024 | Exparel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.58 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $28.22 | 2025 | |
| Allergan, INC. | $24.13 | 2019 | |
| Kerecis Limited | $23.54 | 2022 | |
| Integra Lifesciences Corporation | $20.88 | 2020 | |
| Access Pro Medical, LLC | $19.51 | 2022 | |
| Baxter Healthcare | $17.90 | 2022 | |
| Cook Medical LLC | $15.88 | 2019 | |
| Zyla Life Sciences, INC. | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.